Search Login Register

Ticlopidine (Ticlid) Summary

Description: Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis.

Also Known As: Ticlid; 53-32C; Almirall Brand of Ticlopidine Hydrochloride; Roche Brand of Ticlopidine Hydrochloride; Ticlodix Show All >>

Networked: 1017 relevant articles (102 outcomes, 144 trials/studies) for this Drug

Key Diseases for which Ticlopidine is Relevant

  1. Stroke (Strokes) : 32 outcomes 39 studies in 159 results
  2. Thrombosis (Thrombus) : 17 outcomes 28 studies in 197 results
  3. Myocardial Infarction : 13 outcomes 25 studies in 92 results
  4. Hemorrhage : 4 outcomes 9 studies in 62 results
  5. Neutropenia : 4 outcomes 5 studies in 63 results
Show All >>

Drugs Related to Ticlopidine

  1. Aspirin (Acetylsalicylic Acid)
  2. clopidogrel (Plavix)
  3. Dipyridamole (Persantine)
  4. Platelet Aggregation Inhibitors (Antiplatelet Drugs)
  5. Heparin (Liquaemin)
  6. Warfarin (Coumadin)
  7. cilostazol (Pletal)
  8. Ticlopidine (Ticlid)
  9. thienopyridine
  10. triflusal
Show All >>

Therapies Related to Ticlopidine

  1. Stents
  2. Angioplasty (Angioplasty, Transluminal)
  3. Transplants (Transplant)
  4. Renal Dialysis (Hemodialysis)
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.